Prieto-Pena, D.Calderon-Goercke, M.Bernabeu, P.Vela-Casasempere, P.Narvaez, J.Fernandez-Lopez, C.Freire Gonzalez, M.Gonzalez-Alvarez, B.Solans-Laque, R.Callejas-Rubio, J. L.Ortego, N.Fernandez-Diaz, C.Rubio Romero, E.Garcia Morillo, S.Minguez, M.Fernandez-Carballido, C.De Miguel, E.Melchor, S.Salgado-Perez, E.Bravo, B.Romero-Yuste, S.Salvatierra, J.Hidalgo, C.Manrique Arija, S.Romero-Gomez, C.Moya, P.Alvarez-Rivas, N.Mendizabal, J.Ortiz Sanjuan, F. M.Perez de Pedro, I.Loricera, J.Castaneda, S.Gonzalez-Gay, M. A.Blanco, R.2025-01-072025-01-072020-06-010003-4967https://hdl.handle.net/10668/24406enTOCILIZUMAB IN REFRACTORY TAKAYASU ARTERITIS. OPEN-LABEL NATIONAL MULTICENTER STUDY OF 53 PATIENTS OF CLINICAL PRACTICEconference outputopen access10.1136/annrheumdis-2020-eular.24451468-2060https://ard.bmj.com/content/annrheumdis/79/Suppl_1/1078.2.full.pdf555905003344